LONDON, July 4, 2026, 21:03 BST
- Halma plc (LON:HLMA) ended up 1.11% at £40.14 on Friday, ahead of the FTSE 100 Index (INDEXFTSE:UKX), which added 0.25%.
- The stock gained 2.82% this week but is still off 13.94% on a four-week view, according to London Stock Exchange/FTSE Russell data.
- Halma is set to trade ex-dividend on July 9 for its proposed final dividend of 15.11p.
The London Stock Exchange was closed Saturday. Normal hours for the LSE are 8:00 a.m. to 4:30 p.m., Monday through Friday in London. That means Friday’s close stands as the latest for Halma plc (LON:HLMA) until markets reopen.
Halma gained 1.11% to close at £40.14 on Friday. The FTSE 100 Index (INDEXFTSE:UKX) ended up 0.25% at 10,679.03. Still, Halma is down 18.12% from its June 3 peak of £49.02, so the latest rebound hasn’t made up for the June drop.
The story looks split between a short-term bounce and bigger losses over the past month. London Stock Exchange/FTSE Russell figures show Halma up 2.82% this week, beating the FTSE 350 by 1.19 points. But over the last four weeks, Halma shares are still off 13.94%, trailing the index by 16.84 points. The same data has Halma at £40.14—about 8% under its 50-day average of £43.62, but 4.3% above the 200-day at £38.47.
| Measure | Halma | Index gap |
|---|---|---|
| 1-day price change | up 1.11% | 0.84 points over FTSE 350 |
| 1-week price change | up 2.82% | 1.19 points above FTSE 350 |
| 4-week price change | down 13.94% | 16.84 points below FTSE 350 |
| Year-to-date price change | up 13.45% | 6.24 points ahead of FTSE 350 |
This is key since Halma isn’t a bargain play. LSE/FTSE Russell data shows the company trades at 38.2 times trailing earnings. That’s more than the five-year median of 34.4. The free-cash-flow yield is also thin at 1.35%, below the five-year median 1.54%. If the stock’s going to recover, it’s going to take more than a dividend. Investors have to be convinced the June photonics reset was enough.
| Valuation or technical measure | Latest | 5-year median or reference |
|---|---|---|
| Trailing P/E | 38.2x | 34.4x |
| Price to sales | 5.9x | 5.0x |
| Free cash flow yield | 1.35% | 1.54% |
| Current price vs 50-day avg | 0.92x | 50-day avg: £43.62 |
| Current price vs 200-day avg | 1.04x | 200-day avg: £38.47 |
Halma’s latest news is away from photonics. The company said July 2 it bought itemedical and Naslund Medical for its SSG and IZI Medical units in Healthcare. Itemedical brings in hospital workflow tech, while Naslund adds fiducial marker tech for targeted cancer work. CEO Marc Ronchetti said the new pieces give “complementary capabilities in markets they know well” and are “a strong platform” for growth. Halma
Photonics is still setting prices. Reuters said June 11 that Halma now sees low double-digit organic constant-currency revenue growth for fiscal 2027. That’s down from 16% growth in 2026. The forecast bakes in about five points from photonics. Analysts at JPMorgan Chase & Co NYSE:JPM said that might disappoint. Matthew Donen at Morningstar Inc NASDAQ:MORN said the slower outlook extends to both photonics and the rest of the group.
Halma’s June numbers show why the shares keep their premium. Revenue was up 15% to £2.58 billion. Adjusted EBIT climbed 22% to £594.5 million. Adjusted return on total invested capital hit 16.2%. “We grew revenue to over £2.5bn and Adjusted profit to over £500m,” CEO Ronchetti said, both hitting those marks for the first time. The company said its 2026 dividend will be up 7% to 24.74p a share, marking a 47th consecutive year of dividend growth of 5% or more. Halma
This week holders face a smaller and cleaner test. The proposed final dividend comes to 15.11p per share. The ex-dividend date falls on July 9, with a record date set for July 10. Payment is due August 14, but only if shareholders sign off at the annual meeting on July 23. With shares finishing Friday at 4,014p, the final dividend is about 0.38% of the share price.
